Cargando…

The good and the bad of diabetes mellitus in the critically ill

Diabetes mellitus is increasingly prevalent and associated with significant end organ damage that one may presume to impact upon critical illness. However, Siegelaar and colleagues present data that suggest, excepting those patients admitted to a cardiac intensive care unit, the presence of diabetes...

Descripción completa

Detalles Bibliográficos
Autor principal: Finney, Simon J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388648/
https://www.ncbi.nlm.nih.gov/pubmed/22189003
http://dx.doi.org/10.1186/cc10548
_version_ 1782237218342961152
author Finney, Simon J
author_facet Finney, Simon J
author_sort Finney, Simon J
collection PubMed
description Diabetes mellitus is increasingly prevalent and associated with significant end organ damage that one may presume to impact upon critical illness. However, Siegelaar and colleagues present data that suggest, excepting those patients admitted to a cardiac intensive care unit, the presence of diabetes mellitus is not associated with increased mortality in critically ill patients. It is not possible to unpick how unmeasured parameters such as glycaemic control, the nature of whether type I or type II, or concomitant drug therapy confound the results. Nevertheless, the results are consistent with many risk-adjustment models used in the critically ill, and clinical practice that tolerates mild hyperglycaemia. Is it even possible that diabetes mellitus is protective?
format Online
Article
Text
id pubmed-3388648
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33886482012-07-04 The good and the bad of diabetes mellitus in the critically ill Finney, Simon J Crit Care Commentary Diabetes mellitus is increasingly prevalent and associated with significant end organ damage that one may presume to impact upon critical illness. However, Siegelaar and colleagues present data that suggest, excepting those patients admitted to a cardiac intensive care unit, the presence of diabetes mellitus is not associated with increased mortality in critically ill patients. It is not possible to unpick how unmeasured parameters such as glycaemic control, the nature of whether type I or type II, or concomitant drug therapy confound the results. Nevertheless, the results are consistent with many risk-adjustment models used in the critically ill, and clinical practice that tolerates mild hyperglycaemia. Is it even possible that diabetes mellitus is protective? BioMed Central 2011 2011-12-12 /pmc/articles/PMC3388648/ /pubmed/22189003 http://dx.doi.org/10.1186/cc10548 Text en Copyright ©2011 BioMed Central Ltd
spellingShingle Commentary
Finney, Simon J
The good and the bad of diabetes mellitus in the critically ill
title The good and the bad of diabetes mellitus in the critically ill
title_full The good and the bad of diabetes mellitus in the critically ill
title_fullStr The good and the bad of diabetes mellitus in the critically ill
title_full_unstemmed The good and the bad of diabetes mellitus in the critically ill
title_short The good and the bad of diabetes mellitus in the critically ill
title_sort good and the bad of diabetes mellitus in the critically ill
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388648/
https://www.ncbi.nlm.nih.gov/pubmed/22189003
http://dx.doi.org/10.1186/cc10548
work_keys_str_mv AT finneysimonj thegoodandthebadofdiabetesmellitusinthecriticallyill
AT finneysimonj goodandthebadofdiabetesmellitusinthecriticallyill